查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571847

全球血糖監測系統市場

Blood Glucose Monitoring Systems
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 92 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球血糖監測系統市場預計將達到 400 億美元

2023年全球血糖監測系統市場估計為208億美元，預計2030年將達到400億美元，2023年至2030年複合年成長率為9.8%。自我監測是本報告分析的細分市場之一，預計複合年成長率為 9.3%，到分析期結束時將達到 214 億美元。分析期間，連續細分市場的複合年成長率預計為 10.5%。

美國市場預計54億美元，中國預計複合年成長率13.0%

預計2023年美國血糖監測系統市場規模將達54億美元。中國作為世界第二大經濟體，預計2030年市場規模將達91億美元，2023-2030年分析期間複合年成長率為13.0%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 6.7% 和 7.9%。在歐洲，德國的複合年成長率預計約為 7.5%。

全球血糖監測系統市場—主要趨勢與促進因素總結

血糖監測系統如何隨著科技的進步而發展？

由於技術進步使血糖監測對糖尿病患者來說更加準確、方便和方便用戶使用，血糖監測 (BGM) 系統市場正在經歷重大發展。傳統的血糖值監測方法，例如指尖刺血液測試，正在被連續血糖監測 (CGM) 系統所取代，該系統具有微創性，可即時追蹤血糖濃度。 CGM 系統透過插入皮下的感測器連續測量血糖濃度，使患者和醫療保健提供者能夠更準確地監測趨勢和波動。這種從間歇監測到連續監測的轉變透過允許及時干預和更個人化的治療計劃來改善糖尿病管理。

整合 CGM 技術的穿戴式設備也越來越受歡迎，為患者提供了一種方便、非侵入性的方式來追蹤全天的血糖值。這些設備通常連接到行動應用程式，允許用戶即時查看血糖資料，接收有關危險波動的警報，並與醫療保健提供者共用資訊。此外，人工智慧 (AI) 和資料分析的進步透過啟用預測模型來預測血糖波動並幫助患者採取預防措施，從而提高血糖監測系統的準確性。

CGM 系統如何影響糖尿病管理？

連續血糖監測 (CGM) 系統透過提供更詳細的即時血糖濃度資料，對糖尿病管理產生重大影響。與傳統的血糖儀需要全天多次進行指尖採血測試不同，CGM 系統提供連續的資料流，使用戶能夠監測血糖趨勢和模式。這種即時監測使患者能夠確定不同的活動、飲食和藥物如何影響他們的血糖水平，使他們能夠就降低飲食、運動和胰島素的使用做出明智的決定。

CGM 系統還可以在血糖濃度過高或過低時發送警報，從而提高患者的安全性，有助於防止高血糖或低血糖的危險發作。這項功能對於血糖快速波動風險較高的第 1 型糖尿病患者尤其有益。 CGM 系統還允許醫療保健提供者隨時存取詳細的血糖資料，從而更準確地評估和調整治療計劃。透過提高血糖資料的品質和頻率，CGM 系統正在改變糖尿病護理並改善全球數百萬患者的治療結果。

與行動應用程式和人工智慧的資料整合如何改善血糖監測？

與行動應用程式和人工智慧的資料整合極大地提高了血糖監測系統的功能，使糖尿病管理更加便利和個人化。許多現代血糖監測儀和 CGM 設備都包含藍牙技術，使它們能夠與智慧型手機應用程式同步，從而允許用戶追蹤和管理血糖濃度。這些應用程式通常提供視覺化圖表、歷史資料和趨勢分析，以幫助用戶了解他們隨時間變化的血糖模式。一些應用程式可以記錄您的膳食、身體活動和藥物治療，讓您整體情況糖尿病管理情況。

人工智慧驅動的演算法透過分析過去的資料並根據過去的趨勢預測未來的血糖水平，增強了血糖監測系統的預測能力。這使得患者能夠預測血糖的峰值和下降，並相應地調整他們的行為和胰島素劑量。人工智慧也被用於開發封閉回路型胰島素輸送系統，也稱為人工胰臟系統，可根據即時血糖測量結果自動調整胰島素水平。資料整合和人工智慧的這些進步使血糖監測更加主動，減輕了患者的負擔並改善了整體糖尿病管理。

推動血糖監測系統市場成長的因素有哪些？

血糖監測系統市場的成長是由多種因素推動的，例如全球糖尿病盛行率的增加、血糖監測技術的進步以及穿戴式裝置的日益普及。隨著全球糖尿病盛行率持續上升，特別是在開發中國家，對有效的血糖監測解決方案來幫助患者管理疾病的需求不斷成長。從傳統的指尖採血測試向連續血糖監測 (CGM) 系統的轉變是一個主要驅動力，因為這些設備提供了更準確、即時的資料並減少了侵入性測試的需求。

CGM 系統和行動應用程式整合、人工智慧和資料分析等技術進步也使血糖監測變得更加方便、準確和個人化，從而推動市場成長。穿戴式裝置的日益普及也促進了市場的擴張，因為消費者越來越喜歡非侵入性和互聯的健康管理解決方案。此外，人口老化、久坐生活方式的增加和不健康的飲食導致第 2 型糖尿病盛行率增加，進一步推動了對血糖監測系統的需求。

CGM 系統的監管支援和報銷政策也在推動採用，特別是在北美和歐洲等新興市場。醫療保健提供者和保險公司正在認知到 CGM 系統在改善糖尿病管理和降低與糖尿病併發症相關的長期成本方面的價值。最後，隨著患者更主動地管理疾病和預防併發症，人們對糖尿病和血糖監測重要性的認知不斷提高，這些系統得到了更多的採用。

受訪企業範例（共36家）

  • Abbott Laboratories
  • Acon Laboratories
  • Arkray
  • Ascensia Diabetes Care
  • B. Braun Melsungen
  • Dexcom
  • F. Hoffmann-La Roche
  • Lifescan
  • Medtronic

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP21367

Global Blood Glucose Monitoring Systems Market to Reach US$40.0 Billion by 2030

The global market for Blood Glucose Monitoring Systems estimated at US$20.8 Billion in the year 2023, is expected to reach US$40.0 Billion by 2030, growing at a CAGR of 9.8% over the analysis period 2023-2030. Self-Monitoring, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$21.4 Billion by the end of the analysis period. Growth in the Continuous segment is estimated at 10.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.4 Billion While China is Forecast to Grow at 13.0% CAGR

The Blood Glucose Monitoring Systems market in the U.S. is estimated at US$5.4 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$9.1 Billion by the year 2030 trailing a CAGR of 13.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.7% and 7.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR.

Global Blood Glucose Monitoring Systems Market – Key Trends & Drivers Summarized

How Are Blood Glucose Monitoring Systems Evolving with Technological Advancements?

The blood glucose monitoring (BGM) systems market is undergoing significant evolution due to advancements in technology, which are making glucose monitoring more accurate, convenient, and user-friendly for patients with diabetes. Traditional methods of monitoring blood glucose levels, such as finger-prick tests, are being replaced by continuous glucose monitoring (CGM) systems that offer real-time tracking of glucose levels with minimal invasiveness. CGM systems use sensors inserted under the skin to measure glucose levels continuously, allowing patients and healthcare providers to monitor trends and fluctuations more accurately. This shift from intermittent to continuous monitoring is improving diabetes management by enabling timely interventions and more personalized treatment plans.

Wearable devices integrated with CGM technology are also gaining popularity, providing patients with a convenient, non-invasive way to track their blood glucose levels throughout the day. These devices are often connected to mobile apps, allowing users to view their glucose data in real-time, receive alerts about dangerous fluctuations, and share information with their healthcare providers. Additionally, advancements in artificial intelligence (AI) and data analytics are enhancing the accuracy of blood glucose monitoring systems by enabling predictive modeling, which can anticipate glucose fluctuations and help patients take preventive measures.

What Impact Do CGM Systems Have on Diabetes Management?

Continuous Glucose Monitoring (CGM) systems are having a profound impact on diabetes management by offering more detailed and real-time data on glucose levels, allowing patients to take proactive steps in managing their condition. Unlike traditional blood glucose meters, which require multiple finger-stick tests throughout the day, CGM systems provide a continuous stream of data, enabling users to monitor glucose trends and patterns. This real-time monitoring allows patients to identify how different activities, meals, and medications affect their glucose levels, helping them make informed decisions about their diet, exercise, and insulin use.

CGM systems also enhance safety for patients by sending alerts when glucose levels are too high or too low, helping to prevent dangerous episodes of hyperglycemia or hypoglycemia. This feature is particularly beneficial for patients with type 1 diabetes, who are at greater risk of sudden glucose fluctuations. CGM systems also enable healthcare providers to access detailed glucose data over time, allowing for more accurate assessments and adjustments to treatment plans. By improving the quality and frequency of glucose data, CGM systems are transforming diabetes care and improving outcomes for millions of patients worldwide.

How Is Data Integration with Mobile Apps and AI Improving Blood Glucose Monitoring?

Data integration with mobile apps and AI is significantly improving the functionality of blood glucose monitoring systems, making diabetes management more convenient and personalized. Many modern glucose monitors and CGM devices are now equipped with Bluetooth technology, allowing them to sync with smartphone apps where users can track and manage their glucose levels. These apps often provide visual charts, historical data, and trend analysis, helping users understand their glucose patterns over time. Some apps also allow users to log meals, physical activity, and medications, providing a holistic view of their diabetes management.

AI-powered algorithms are enhancing the predictive capabilities of blood glucose monitoring systems by analyzing historical data and predicting future glucose levels based on past trends. This can help patients anticipate glucose spikes or drops and adjust their behavior or insulin dosing accordingly. AI is also being used to develop closed-loop insulin delivery systems, also known as artificial pancreas systems, which automatically adjust insulin levels in response to real-time glucose readings. These advancements in data integration and AI are making blood glucose monitoring more proactive, reducing the burden on patients and improving overall diabetes management.

What Factors Are Driving the Growth of the Blood Glucose Monitoring Systems Market?

The growth in the blood glucose monitoring systems market is driven by several factors, including the increasing prevalence of diabetes worldwide, advancements in glucose monitoring technology, and the growing adoption of wearable devices. As the global incidence of diabetes continues to rise, particularly in developing countries, there is a growing demand for effective glucose monitoring solutions that help patients manage their condition. The shift from traditional finger-stick testing to continuous glucose monitoring (CGM) systems is a key growth driver, as these devices offer more accurate, real-time data and reduce the need for invasive testing.

Technological advancements, such as the integration of CGM systems with mobile apps, AI, and data analytics, are also driving market growth by making glucose monitoring more convenient, accurate, and personalized. The growing popularity of wearable devices is another factor contributing to the expansion of the market, as consumers increasingly prefer non-invasive, connected solutions for managing their health. In addition, the aging population and the rise in sedentary lifestyles and unhealthy diets are leading to an increased prevalence of type 2 diabetes, further fueling the demand for blood glucose monitoring systems.

Regulatory support and reimbursement policies for CGM systems are also driving adoption, particularly in developed markets such as North America and Europe. Healthcare providers and insurance companies are recognizing the value of CGM systems in improving diabetes management and reducing the long-term costs associated with diabetes complications. Finally, increasing awareness about diabetes and the importance of glucose monitoring is leading to greater adoption of these systems, as patients become more proactive in managing their condition and preventing complications.

Select Competitors (Total 36 Featured) -

  • Abbott Laboratories
  • Acon Laboratories
  • Arkray
  • Ascensia Diabetes Care
  • B. Braun Melsungen
  • Dexcom
  • F. Hoffmann-La Roche
  • Lifescan
  • Medtronic

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Blood Glucose Monitoring Systems - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Diabetes Globally Drives Demand for Blood Glucose Monitoring Systems
    • Increasing Focus on Personalized Healthcare Expands the Addressable Market for Continuous Glucose Monitoring (CGM) Systems
    • Technological Advancements in Blood Glucose Monitoring Devices Propel Growth in Accuracy and Usability
    • Growing Demand for Wearable and Non-Invasive Blood Glucose Monitoring Devices Fuels Innovation
    • Rising Awareness of Diabetes Management and Preventive Care Strengthens Market Growth for Blood Glucose Monitors
    • Integration of AI and Data Analytics in Glucose Monitoring Systems Expands Opportunities for Personalized Treatment
    • Increasing Focus on Remote Patient Monitoring and Telehealth Solutions Expands Market Adoption of Blood Glucose Monitoring Systems
    • Growing Use of Continuous Glucose Monitoring Systems in Pediatric and Geriatric Diabetes Management Drives Demand
    • Rising Adoption of Smart Insulin Pens and Automated Insulin Delivery Systems Propels Demand for Integrated Monitoring Solutions
    • Increasing Use of Blood Glucose Monitoring Systems in Hospital and Clinical Settings Expands Market Applications
    • Technological Advancements in Sensor Accuracy and Battery Life Strengthen the Business Case for Wearable Glucose Monitors
    • Rising Demand for Glucose Monitoring Apps and Digital Health Platforms Drives Adoption of Connected Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Blood Glucose Monitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Blood Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Self-Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Self-Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Self-Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Continuous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Continuous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Continuous by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Fingertip Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Fingertip Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Fingertip Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Alternate Site Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Alternate Site Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Alternate Site Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Self / Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Self / Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Self / Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Type 1 Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Type 1 Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Type 1 Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Type 2 Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Type 2 Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Type 2 Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 28: World Blood Glucose Monitoring Systems Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: China 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: China 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: China 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Blood Glucose Monitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • FRANCE
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 95: France Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: France 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: France 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: France 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 104: France Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: France 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Germany 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Germany 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 113: Germany Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Germany 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 116: Germany Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Germany Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Germany 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 119: Italy Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Italy Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Italy 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 122: Italy Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Italy Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Italy 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 125: Italy Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Italy Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Italy 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 128: Italy Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Italy 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 131: UK Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: UK Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: UK 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 134: UK Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: UK Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: UK 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 137: UK Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: UK Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: UK 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 140: UK Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: UK 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 143: Spain Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Spain Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Spain 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 146: Spain Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Spain Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Spain 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 149: Spain Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Spain Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Spain 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 152: Spain Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Spain Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Spain 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 155: Russia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Russia Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Russia 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 158: Russia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Russia Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Russia 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 161: Russia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Russia Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Russia 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 164: Russia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Russia Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Russia 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 167: Rest of Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of Europe Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Rest of Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 170: Rest of Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Rest of Europe Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Rest of Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Rest of Europe Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Rest of Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Rest of Europe Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Rest of Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 179: Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 180: Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 182: Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 194: Australia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Australia Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Australia 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 197: Australia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Australia Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Australia 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 200: Australia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Australia Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Australia 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 203: Australia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Australia Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Australia 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • INDIA
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 206: India Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: India Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: India 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 209: India Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: India Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: India 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 212: India Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: India Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: India 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 215: India Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: India Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: India 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 218: South Korea Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: South Korea Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: South Korea 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 221: South Korea Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 222: South Korea Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 223: South Korea 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 224: South Korea Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 225: South Korea Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 226: South Korea 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 227: South Korea Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 228: South Korea Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 229: South Korea 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 230: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Rest of Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 232: Rest of Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 233: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 237: Rest of Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 238: Rest of Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Rest of Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 241: Rest of Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 242: Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 243: Latin America Historic Review for Blood Glucose Monitoring Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 244: Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 245: Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Latin America Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 247: Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 248: Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Latin America Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 250: Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 251: Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Latin America Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 253: Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 254: Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Latin America Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 256: Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 257: Argentina Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Argentina Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 259: Argentina 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 260: Argentina Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Argentina Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 262: Argentina 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 263: Argentina Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Argentina Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 265: Argentina 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 266: Argentina Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Argentina Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 268: Argentina 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 269: Brazil Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Brazil Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 271: Brazil 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 272: Brazil Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Brazil Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 274: Brazil 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 275: Brazil Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 276: Brazil Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 277: Brazil 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 278: Brazil Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 279: Brazil Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 280: Brazil 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 281: Mexico Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 282: Mexico Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 283: Mexico 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 284: Mexico Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 285: Mexico Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 286: Mexico 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 287: Mexico Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 288: Mexico Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 289: Mexico 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 290: Mexico Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Mexico Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 292: Mexico 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 293: Rest of Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Rest of Latin America Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 295: Rest of Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 296: Rest of Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Rest of Latin America Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 298: Rest of Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Rest of Latin America Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 301: Rest of Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 303: Rest of Latin America Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 304: Rest of Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 305: Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 306: Middle East Historic Review for Blood Glucose Monitoring Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 307: Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 308: Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 309: Middle East Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 310: Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 311: Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 312: Middle East Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 313: Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 314: Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 315: Middle East Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 316: Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 317: Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 318: Middle East Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 319: Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 320: Iran Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 321: Iran Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 322: Iran 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 323: Iran Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 324: Iran Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 325: Iran 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 326: Iran Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 327: Iran Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 328: Iran 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 329: Iran Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 330: Iran Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 331: Iran 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 332: Israel Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 333: Israel Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 334: Israel 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 335: Israel Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 336: Israel Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 337: Israel 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 338: Israel Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 339: Israel Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 340: Israel 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 341: Israel Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 342: Israel Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 343: Israel 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 344: Saudi Arabia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 345: Saudi Arabia Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 346: Saudi Arabia 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 347: Saudi Arabia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 348: Saudi Arabia Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 349: Saudi Arabia 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 351: Saudi Arabia Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 352: Saudi Arabia 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 354: Saudi Arabia Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 355: Saudi Arabia 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 356: UAE Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 357: UAE Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 358: UAE 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 359: UAE Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 360: UAE Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 361: UAE 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 362: UAE Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 363: UAE Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 364: UAE 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 365: UAE Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 366: UAE Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 367: UAE 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 368: Rest of Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 369: Rest of Middle East Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 370: Rest of Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 371: Rest of Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 372: Rest of Middle East Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 373: Rest of Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 375: Rest of Middle East Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 376: Rest of Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 378: Rest of Middle East Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 379: Rest of Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • AFRICA
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 380: Africa Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 381: Africa Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 382: Africa 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 383: Africa Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 384: Africa Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 385: Africa 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 386: Africa Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 387: Africa Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 388: Africa 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 389: Africa Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 390: Africa Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 391: Africa 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION